Found: 7
Select item for more details and to access through your institution.
Low Dose Aspirin Therapy Decreases Blood Glucose Levels but Does not Prevent Type I Diabetes-induced Bone Loss.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2011, v. 28, n. 5, p. 923, doi. 10.1159/000335806
- By:
- Publication type:
- Article
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.
- Published in:
- FASEB Journal, 2018, v. 32, n. 7, p. 3752, doi. 10.1096/fj.201700667R
- By:
- Publication type:
- Article
Bone Disease in Type 1 Diabetes.
- Published in:
- Current Medical Literature: Diabetes, 2010, v. 27, n. 4, p. 113
- By:
- Publication type:
- Article
Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity.
- Published in:
- Journal of Cellular Biochemistry, 2011, v. 112, n. 9, p. 2403, doi. 10.1002/jcb.23163
- By:
- Publication type:
- Article
Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
- Published in:
- Journal of Cellular Physiology, 2015, v. 230, n. 8, p. 1944, doi. 10.1002/jcp.24929
- By:
- Publication type:
- Article
Both spontaneous Ins2<sup>+/−</sup> and streptozotocin-induced type I diabetes cause bone loss in young mice.
- Published in:
- Journal of Cellular Physiology, 2013, v. 228, n. 4, p. 689, doi. 10.1002/jcp.24177
- By:
- Publication type:
- Article
The bone marrow microenvironment contributes to type I diabetes induced osteoblast death.
- Published in:
- Journal of Cellular Physiology, 2011, v. 226, n. 2, p. 477, doi. 10.1002/jcp.22357
- By:
- Publication type:
- Article